tendon: what the trials say vs what this community says
tendon: what the trials say vs what this community says — a position I have arrived at slowly and would like tested. The evidence base, described honestly, which almost no summary of it does. The published literature is overwhelmingly preclinical and largely in rodent models. The individual papers are generally more…
Paid for identity confirmation rather than just purity for the first time here. Worth it, and it is not the default on most certificates.
That claim traces back to a single preclinical paper that says something considerably narrower.
Small fix — fifteen residues, not seventeen. The sequence is public and easy to check.
no clinical trial has established what these threads assert
pentadecapeptide, fifteen residues, and the sequence is public
Same. Solution stability is the practical question and almost nobody asks it.
Right, and regulatory status has genuinely moved in several jurisdictions. Answers from three years ago may be wrong now.
the human evidence is thin and the rodent evidence is not
Went and read the primary rodent papers after arguing about a summary for a week. They are much narrower than the threads suggest.
Bought small, tested identity first, and only then thought about anything else. That order felt right.
regulatory status varies by jurisdiction and it has moved recently
identity, quantity, stability — three separate questions